glp-1 drugs approved for weight loss Popular medications may have health benefits that extend beyond and blood sugar control, a new study finds Comparing GLP‑1 Drugs With Other
Description
Published 2022 Mar 15

Discovery of the once-weekly glucagon-like Peptide-1 (GLP-1) analogue Semaglutide
This effect is achieved by reducing the expression of Trem2 and NFATc1 and downregulating the expression of CTSK and TRAP to inhibit bone resorption activity
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Guardado Mendoza R, Perego C, Finzi G, et al

[DOI] [PubMed] [Google Scholar] 92.Coskun T, et al

OW, overweight
